Bioactive coatings for orthopaedic implants-recent trends in development of implant coatings

International Journal of Molecular Sciences

Volumn 15, Issue 7, 2014, Pages 11878-11921

  Zhang, Bill G X ^a,b   Myers, Damian E ^a,b   Wallace, Gordon G ^c   Brandt, Milan ^d   Choong, Peter F M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d RMIT UNIVERSITY   (Australia)

Author keywords

Antimicrobial; Biofilm; Coating; Implant; Infection; Orthopaedic; Osteoconduction; Osteoinduction; Osteointegration; Silver

Indexed keywords

ALKALINE PHOSPHATASE; BETA1 INTEGRIN; BIOMATERIAL; BIOMIMETIC MATERIAL; CALCIUM PHOSPHATE CERAMIC; CHONDROITIN SULFATE; COLLAGEN TYPE 1; DICKKOPF 2 PROTEIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; FOCAL ADHESION KINASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROXYAPATITE; NANOPARTICLE; NANOTUBE; OSTEOPROTEGERIN; PROSTAGLANDIN E2; TITANIUM; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 2; VITRONECTIN RECEPTOR; CERAMICS; SCLEROPROTEIN;

ARTHROPLASTY; BIOCOMPATIBILITY; BONE MINERALIZATION; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HUMAN; JOINT PROSTHESIS; MATERIAL COATING; METAL IMPLANTATION; ORTHOPEDIC IMPLANT; OSSIFICATION; PHOTOCATALYSIS; PROSTHESIS LOOSENING; REVIEW; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TOPOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; ANIMAL; CERAMICS; CHEMISTRY;

ANIMALS; CERAMICS; COATED MATERIALS, BIOCOMPATIBLE; EXTRACELLULAR MATRIX PROTEINS; HUMANS; JOINT PROSTHESIS;

EID: 84903899166     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150711878     Document Type: Review

References (304)

1. Australian Orthopaedic Association National Joint Replacement Registry 2013, Annual Report, 2013 Available online: https: //aoanjrr.dmac.adelaide.edu.au/annual-reports-2013 (accessed on 30 June 2014).
2. Albrektsson, T.; Johansson, C. Osteoinduction, osteoconduction and osseointegration. Eur. Spine J. 2001, 10, S96-S101.
3. Bobyn, J.D.; Thompson, R.; Lim, L.; Pura, J.A.; Bobyn, K.; Tanzer, M. Local alendronic acid elution increases net periimplant bone formation: A micro-CT analysis. Clin. Orthop. Relat. Res. 2014, 472, 687-694.
4. Yang, F.; Yang, D.; Tu, J.; Zheng, Q.; Cai, L.; Wang, L. Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling. Stem Cells 2011, 29, 981-991.
5. Park, J.W.; Park, K.B.; Suh, J.Y. Effects of calcium ion incorporation on bone healing of Ti6Al4V alloy implants in rabbit tibiae. Biomaterials 2007, 28, 3306-3313.
6. Soballe, K. Hydroxyapatite ceramic coating for bone implant fixation. Mechanical and histological studies in dogs. Acta Orthop. Scand. Suppl. 1993, 255, 1-58.
7. Toquet, J.; Rohanizadeh, R.; Guicheux, J.; Couillaud, S.; Passuti, N.; Daculsi, G.; Heymann, D. Osteogenic potential in vitro of human bone marrow cells cultured on macroporous biphasic calcium phosphate ceramic. J. Biomed. Mater. Res. 1999, 44, 98-108.
8. Uludag, H.; D'Augusta, D.; Palmer, R.; Timony, G.; Wozney, J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mater. Res. 1999, 46, 193-202.
9. Rammelt, S.; Illert, T.; Bierbaum, S.; Scharnweber, D.; Zwipp, H.; Schneiders, W. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate. Biomaterials 2006, 27, 5561-5571.
10. Ferris, D.M.; Moodie, G.D.; Dimond, P.M.; Gioranni, C.W.; Ehrlich, M.G.; Valentini, R.F. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials 1999, 20, 2323-2331.
11. Shimazaki, T.; Miyamoto, H.; Ando, Y.; Noda, I.; Yonekura, Y.; Kawano, S. Miyazaki, M.; Mawatari, M.; Hotokebuchi, T. In vivo antibacterial and silver-releasing properties of novel thermal sprayed silver-containing hydroxyapatite coating. J. Biomed. Mater. Res. B Appl. Biomater. 2010, 92, 386-389.
12. Nablo, B.J.; Prichard, H.L.; Butler, R.D.; Klitzman, B. Schoenfisch MH Inhibition of implant-associated infections via nitric oxide release. Biomaterials 2005, 26, 6984-6990.
13. Oka, Y.; Kim, W.C.; Yoshida, T.; Hirashima, T.; Mouri, H.; Urade, H.; Itoh, Y.; Kubo, T. Efficacy of titanium dioxide photocatalyst for inhibition of bacterial colonization on percutaneous implants. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 86, 530-540.
14. Vester, H.; Wildemann, B.; Schmidmaier, G.; Stockle, U.; Lucke, M. Gentamycin delivered from a PDLLA coating of metallic implants: In vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis. Injury 2010, 41, 1053-1059.
15. DeJong, E.S.; DeBerardino, T.M.; Brooks, D.E.; Nelson, B.J.; Campbell, A.A.; Bottoni, C.R.; Pusateri, A.E.; Walton, R.S.; Guymon, C.H.; McManus, A.T. Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/chlorhexidine complex to prevent pin tract infection in a goat model. J. Trauma 2001, 50, 1008-1014.
16. Antoci, V., Jr.; Adams, C.S.; Hickok, N.J.; Shapiro, I.M.; Parvizi, J. Vancomycin bound to Ti rods reduces periprosthetic infection: Preliminary study. Clin. Orthop. Relat. Res. 2007, 461, 88-95.
17. 2 nanotubes: In vivo and in vitro studies. Int. J. Nanomed. 2013, 8, 4379-4389.
18. Humblot, V.; Yala, J.F.; Thebault, P.; Boukerma, K.; Hequet, A.; Berjeaud, J.M.; Pradier, C.M. The antibacterial activity of Magainin I immobilized onto mixed thiols self-assembled monolayers. Biomaterials 2009, 30, 3503-3512.
19. Schwartz, Z.; Lohmann, C.H.; Oefinger, J.; Bonewald, L.F.; Dean, D.D.; Boyan, B.D. Implant surface characteristics modulate differentiation behavior of cells in the osteoblastic lineage. Adv. Dent. Res. 1999, 13, 38-48.
20. Lincks, J.; Boyan, B.D.; Blanchard, C.R.; Lohmann, C.H.; Liu, Y.; Cochran, D.L.; Dean, D.D.; Schwartz, Z. Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition. Biomaterials 1998, 19, 2219-2232.
21. Batzer, R.; Liu, Y.; Cochran, D.L.; Szmuckler-Moncler, S.; Dean, D.D.; Boyan, B.D.; Schwartz, Z. Prostaglandins mediate the effects of titanium surface roughness on MG63 osteoblast-like cells and alter cell responsiveness to 1α, 25-(OH)2D3. J. Biomed. Mater. Res. 1998, 41, 489-496.
22. Boyan, B.D.; Batzer, R.; Kieswetter, K.; Liu, Y.; Cochran, D.L.; Szmuckler-Moncler, S.; Dean, D.D.; Schwartz, Z. Titanium surface roughness alters responsiveness of MG63 osteoblast-like cells to 1α, 25-(OH)2D3. J. Biomed. Mater. Res. 1998, 39, 77-85.
23. Kieswetter, K.; Schwartz, Z.; Hummert, T.W.; Cochran, D.L.; Simpson, J.; Dean, D.D. Boyan, B.D. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG-63 cells. J. Biomed. Mater. Res. 1996, 32, 55-63.
24. Lossdorfer, S.; Schwartz, Z.; Wang, L.; Lohmann, C.H.; Turner, J.D.; Wieland, M.; Cochran, D.L.; Boyan, B.D. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. J. Biomed. Mater. Res. A 2004, 70, 361-369.
25. Olivares-Navarrete, R.; Hyzy, S.L.; Hutton, D.L.; Erdman, C.P.; Wieland, M.; Boyan, B.D. Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage. Biomaterials 2010, 31, 2728-2735.
26. Raines, A.L.; Olivares-Navarrete, R.; Wieland, M.; Cochran, D.L.; Schwartz, Z.; Boyan, B.D.; Schwartz, Z. Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy. Biomaterials 2010, 31, 4909-4917.
27. Olivares-Navarrete, R.; Raz, P.; Zhao, G.; Chen, J.; Wieland, M.; Cochran, D.L.; Chaudhri, R.A.; Ornoy, A.; Boyan, B.D.; Schwartz, Z. Integrin α2β1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates. Proc. Natl. Acad. Sci. USA 2008, 105, 15767-15772.
28. Wang, L.; Zhao, G.; Olivares-Navarrete, R.; Bell, B.F.; Wieland, M.; Cochran, D.L.; Schwartz, Z.; Boyan, B.D. Integrin β1 silencing in osteoblasts alters substrate-dependent responses to 1, 25-dihydroxy vitamin D3. Biomaterials 2006, 27, 3716-3725.
29. Dimitriou, R.; Tsiridis, E.; Giannoudis, P.V. Current concepts of molecular aspects of bone healing. Injury 2005, 36, 1392-1404.
30. Li, X.; Liu, P.; Liu, W.; Maye, P.; Zhang, J.; Zhang, Y.; Hurley, M.; Guo, C.; Boskey, A.; Sun, L.; et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat. Genet. 2005, 37, 945-952.
31. Conconi, M.T.; Tommasini, M.; Baiguera, S.; de Coppi, P.; Parnigotto, P.P.; Nussdorfer, G.G. Effects of prostaglandins E1 and E2 on the growth and differentiation of osteoblast-like cells cultured in vitro. Int. J. Mol. Med. 2002, 10, 451-456.
32. Khosla, S. Minireview: The OPG/RANKL/RANK system. Endocrinology 2001, 142, 5050-5055.
33. Schwartz, Z.; Raines, A.L.; Boyan, B.D. The effect of substrate microtopography on osseointegration of titanium implants. In Comprehensive Biomaterials; Ducheyne, P., Healy, K.E., Hutmacher, D.W., Grainger, D.W., Kirkpatrick, C.J., Eds.; Elsevier: Amsterdam, The Netherlands, 2011; pp. 343-352.
34. Junker, R.; Dimakis, A.; Thoneick, M.; Jansen, J.A. Effects of implant surface coatings and composition on bone integration: A systematic review. Clin. Oral Implant. Res. 2009, 20, 185-206.
35. Farzin, A.; Ahmadian, M.; Fathi, M.H. Comparative evaluation of biocompatibility of dense nanostructured and microstructured Hydroxyapatite/Titania composites. Mater. Sci. Eng. C Mater. Biol. Appl. 2013, 33, 2251-2257.
36. Balasundaram, G.; Sato, M.; Webster, T.J. Using hydroxyapatite nanoparticles and decreased crystallinity to promote osteoblast adhesion similar to functionalizing with RGD. Biomaterials 2006, 27, 2798-2805.
37. Dalby, M.J.; McCloy, D.; Robertson, M.; Wilkinson, C.D.; Oreffo, R.O. Osteoprogenitor response to defined topographies with nanoscale depths. Biomaterials 2006, 27, 1306-1315.
38. Palin, E.; Liu, H.; Webster, T. Mimicking the nanofeatures of bone increases bone-forming cell adhesion and proliferation. Nanotechnology 2005, 16, doi: 10.1088/0957-4484/16/9/069.
39. Webster, T.J.; Ejiofor, J.U. Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, and CoCrMo. Biomaterials 2004, 25, 4731-4739.
40. Webster, T.J.; Ergun, C.; Doremus, R.H.; Siegel, R.W.; Bizios, R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J. Biomed. Mater. Res. 2000, 51, 475-483.
41. Webster, T.J.; Schadler, L.S.; Siegel, R.W.; Bizios, R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng. 2001, 7, 291-301.
42. Webster, T.J.; Siegel, R.W.; Bizios, R. Osteoblast adhesion on nanophase ceramics. Biomaterials 1999, 20, 1221-1227.
43. Zhao, G.; Schwartz, Z.; Wieland, M.; Rupp, F.; Geis-Gerstorfer, J.; Cochran, D.L.; Boyan, B.D. High surface energy enhances cell response to titanium substrate microstructure. J. Biomed. Mater. Res. A 2005, 74, 49-58.
44. Zhao, G.; Raines, A.L.; Wieland, M.; Schwartz, Z.; Boyan, B.D. Requirement for both micronand submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography. Biomaterials 2007, 28, 2821-2829.
45. Webster, T.J.; Ergun, C.; Doremus, R.H.; Siegel, R.W.; Bizios, R. Enhanced osteoclast-like cell functions on nanophase ceramics. Biomaterials 2001, 22, 1327-1333.
46. Gittens, R.A.; Olivares-Navarrete, R.; McLachlan, T.; Cai, Y.; Hyzy, S.L.; Schneider, J.M.; Schwartz, Z.; Sandhage, K.H.; Boyan, B.D. Differential responses of osteoblast lineage cells to nanotopographically-modified, microroughened titanium-aluminum-vanadium alloy surfaces. Biomaterials 2012, 33, 8986-8994.
47. Dalby, M.J.; Gadegaard, N.; Tare, R.; Andar, A.; Riehle, M.O.; Herzyk, P.; Wilkinson, C.D.; Oreffo, R.O. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat. Mater. 2007, 6, 997-1003.
48. Ryan, G.; Pandit, A.; Apatsidis, D.P. Fabrication methods of porous metals for use in orthopaedic applications. Biomaterials 2006, 27, 2651-2670.
49. Yoshikawa, H.; Tamai, N.; Murase, T.; Myoui, A. Interconnected porous hydroxyapatite ceramics for bone tissue engineering. J. R. Soc. Interface 2009, 6, S341-S348.
50. Stamp, R.; Fox, P.; O'Neill, W.; Jones, E.; Sutcliffe, C. The development of a scanning strategy for the manufacture of porous biomaterials by selective laser melting. J. Mater. Sci. Mater. Med. 2009, 20, 1839-1848.
51. Bobyn, J.D.; Pilliar, R.M.; Cameron, H.U.; Weatherly, G.C. The optimum pore size for the fixation of porous-surfaced metal implants by the ingrowth of bone. Clin. Orthop. Relat. Res. 1980, 150, 263-270.
52. Niles, J.L.; Coletti, J.M., Jr.; Wilson, C. Biomechanical evaluation of bone-porous material interfaces. J. Biomed. Mater. Res. 1973, 7, 231-251.
53. Cook, S.D.; Walsh, K.A.; Haddad, R.J., Jr. Interface mechanics and bone growth into porous Co-Cr-Mo alloy implants. Clin. Orthop. Relat. Res. 1985, 193, 271-280.
54. Hulbert, S.F.; Morrison, S.J.; Klawitter, J.J. Tissue reaction to three ceramics of porous and non-porous structures. J. Biomed. Mater. Res. 1972, 6, 347-374.
55. Flatley, T.J.; Lynch, K.L.; Benson, M. Tissue response to implants of calcium phosphate ceramic in the rabbit spine. Clin. Orthop. Relat. Res. 1983, 179, 246-252.
56. Lim, J.Y.; Shaughnessy, M.C.; Zhou, Z.; Noh, H.; Vogler, E.A.; Donahue, H.J. Surface energy effects on osteoblast spatial growth and mineralization. Biomaterials 2008, 29, 1776-1784.
57. Lai, H.C.; Zhuang, L.F.; Liu, X.; Wieland, M.; Zhang, Z.Y. The influence of surface energy on early adherent events of osteoblast on titanium substrates. J. Biomed. Mater. Res. A 2010, 93, 289-296.
58. Qu, Z.; Rausch-Fan, X.; Wieland, M.; Matejka, M.; Schedle, A. The initial attachment and subsequent behavior regulation of osteoblasts by dental implant surface modification. J. Biomed. Mater. Res. A 2007, 82, 658-668.
59. Lim, J.Y.; Taylor, A.F.; Li, Z.; Vogler, E.A.; Donahue, H.J. Integrin expression and osteopontin regulation in human fetal osteoblastic cells mediated by substratum surface characteristics. Tissue Eng. 2005, 11, 19-29.
60. Wall, I.; Donos, N.; Carlqvist, K.; Jones, F.; Brett, P. Modified titanium surfaces promote accelerated osteogenic differentiation of mesenchymal stromal cells in vitro. Bone 2009, 45, 17-26.
61. Liu, Q.; Ding, J.; Mante, F.K.; Wunder, S.L.; Baran, G.R. The role of surface functional groups in calcium phosphate nucleation on titanium foil: A self-assembled monolayer technique. Biomaterials 2002, 23, 3103-3111.
62. Takadama, H.; Kim, H.M.; Kokubo, T.; Nakamura, T. TEM-EDX study of mechanism of bonelike apatite formation on bioactive titanium metal in simulated body fluid. J. Biomed. Mater. Res. 2001, 57, 441-448.
63. Fujibayashi, S.; Neo, M.; Kim, H.M.; Kokubo, T.; Nakamura, T. Osteoinduction of porous bioactive titanium metal. Biomaterials 2004, 25, 443-450.
64. Shu, R.; McMullen, R.; Baumann, M.J.; McCabe, L.R. Hydroxyapatite accelerates differentiation and suppresses growth of MC3T3-E1 osteoblasts. J. Biomed. Mater. Res. A 2003, 67, 1196-1204.
65. Xie, J.; Baumann, M.J.; McCabe, L.R. Osteoblasts respond to hydroxyapatite surfaces with immediate changes in gene expression. J. Biomed. Mater. Res. A 2004, 71, 108-117.
66. Mello, A.; Hong, Z.; Rossi, A.M.; Luan, L.; Farina, M.; Querido, W.; Eon, J.; Terra, J.; Balasundaram, G.; Webster, T.; et al. Osteoblast proliferation on hydroxyapatite thin coatings produced by right angle magnetron sputtering. Biomed. Mater. 2007, 2, 67-77.
67. Smith, I.O.; McCabe, L.R.; Baumann, M.J. MC3T3-E1 osteoblast attachment and proliferation on porous hydroxyapatite scaffolds fabricated with nanophase powder. Int. J. Nanomed. 2006, 1, 189-194.
68. Chang, B.S.; Lee, C.K.; Hong, K.S.; Youn, H.J.; Ryu, H.S.; Chung, S.S.; Park, K.W. Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials 2000, 21, 1291-1298.
69. Geesink, R.; de Groot, K.; Klein, C. Chemical implant fixation using hydroxyl-apatite coatings. The development of a human total hip prosthesis for chemical fixation to bone using hydroxyl-apatite coatings on titanium substrates. Clin. Orthop. Relat. Res. 1987, 225, 147-170.
70. He, J.; Huang, T.; Gan, L.; Zhou, Z.; Jiang, B.; Wu, Y.; Wu, F.; Gu, Z. Collagen-infiltrated porous hydroxyapatite coating and its osteogenic properties: In vitro and in vivo study. J. Biomed. Mater. Res. A 2012, 100, 1706-1715.
71. Rajaratnam, S.S.; Jack, C.; Tavakkolizadeh, A.; George, M.D.; Fletcher, R.J.; Hankins, M.; Shepperd, J.A. Long-term results of a hydroxyapatite-coated femoral component in total hip replacement: A 15-to 21-year follow-up study. J. Bone Jt. Surg. Br. 2008, 90, 27-30.
72. Boden, H.; Salemyr, M.; Skoldenberg, O.; Ahl, T.; Adolphson, P. Total hip arthroplasty with an uncemented hydroxyapatite-coated tapered titanium stem: Results at a minimum of 10 years' follow-up in 104 hips. J. Orthop. Sci. 2006, 11, 175-179.
73. Voigt, J.D.; Mosier, M. Hydroxyapatite (HA) coating appears to be of benefit for implant durability of tibial components in primary total knee arthroplasty. Acta Orthop. 2011, 82, 448-459.
74. Epinette, J.A.; Manley, M.T. Uncemented stems in hip replacement-Hydroxyapatite or plain porous: Does it matter? Based on a prospective study of HA Omnifit stems at 15-years minimum follow-up. Hip Int. 2008, 18, 69-74.
75. Goosen, J.H.; Kums, A.J.; Kollen, B.J.; Verheyen, C.C. Porous-coated femoral components with or without hydroxyapatite in primary uncemented total hip arthroplasty: A systematic review of randomized controlled trials. Arch. Orthop. Trauma Surg. 2009, 129, 1165-1169.
76. Camazzola, D.; Hammond, T.; Gandhi, R.; Davey, J.R. A randomized trial of hydroxyapatite-coated femoral stems in total hip arthroplasty: A 13-year follow-up. J. Arthroplast. 2009, 24, 33-37.
77. Lee, J.M.; Lee, C.W. Comparison of hydroxyapatite-coated and non-hydroxyapatite-coated noncemented total hip arthroplasty in same patients. J. Arthroplast. 2007, 22, 1019-1023.
78. Gandhi, R.; Davey, J.R.; Mahomed, N.N. Hydroxyapatite coated femoral stems in primary total hip arthroplasty: A meta-analysis. J. Arthroplast. 2009, 24, 38-42.
79. Lazarinis, S.; Karrholm, J.; Hailer, N.P. Increased risk of revision of acetabular cups coated with hydroxyapatite. Acta Orthop. 2010, 81, 53-59.
80. Lazarinis, S.; Karrholm, J.; Hailer, N.P. Effects of hydroxyapatite coating of cups used in hip revision arthroplasty. Acta Orthop. 2012, 83, 427-435.
81. Lazarinis, S.; Karrholm, J.; Hailer, N.P. Effects of hydroxyapatite coating on survival of an uncemented femoral stem. A Swedish Hip Arthroplasty Register study on 4772 hips. Acta Orthop. 2011, 82, 399-404.
82. Wongwitwichot, P.; Kaewsrichan, J.; Chua, K.H.; Ruszymah, B.H. Comparison of TCP and TCP/HA hybrid scaffolds for osteoconductive activity. Open Biomed. Eng. J. 2010, 4, 279-285.
83. Daculsi, G.; LeGeros, R.Z.; Nery, E.; Lynch, K.; Kerebel, B. Transformation of biphasic calcium phosphate ceramics in vivo: Ultrastructural and physicochemical characterization. J. Biomed. Mater. Res. 1989, 23, 883-894.
84. Daculsi, G.; Laboux, O.; Malard, O.; Weiss, P. Current state of the art of biphasic calcium phosphate bioceramics. J. Mater. Sci. Mater. Med. 2003, 14, 195-200.
85. Heughebaert, M.; LeGeros, R.Z.; Gineste, M.; Guilhem, A.; Bonel, G. Physicochemical characterization of deposits associated with HA ceramics implanted in nonosseous sites. J. Biomed. Mater. Res. 1988, 22, 257-268.
86. Barrere, F.; van Blitterswijk, C.A.; de Groot, K. Bone regeneration: Molecular and cellular interactions with calcium phosphate ceramics. Int. J. Nanomed. 2006, 1, 317-332.
87. LeGeros, R.Z. Properties of osteoconductive biomaterials: Calcium phosphates. Clin. Orthop. Relat. Res. 2002, 395, 81-98.
88. De Groot, K.; Wolke, J.G.; Jansen, J.A. Calcium phosphate coatings for medical implants. Proc. Inst. Mech. Eng. H 1998, 212, 137-147.
89. Bercovy, M.; Beldame, J.; Lefebvre, B.; Duron, A. A prospective clinical and radiological study comparing hydroxyapatite-coated with cemented tibial components in total knee replacement. J. Bone Jt. Surg. Br. 2012, 94, 497-503.
90. Mohseni, E.; Zalnezhad, E.; Bushroa, A.R. Comparative investigation on the adhesion of hydroxyapatite coating on Ti-6Al-4V implant: A review paper. Int. J. Adhes. Adhes. 2014, 48, 238-257.
91. Le Guehennec, L.; Soueidan, A.; Layrolle, P.; Amouriq, Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent. Mater. 2007, 23, 844-854.
92. Reikeras, O.; Gunderson, R.B. Failure of HA coating on a gritblasted acetabular cup: 155 Patients followed for 7-10 years. Acta Orthop. Scand. 2002, 73, 104-108.
93. Dorozhkin, S.V. Biphasic, triphasic and multiphasic calcium orthophosphates. Acta Biomater. 2012, 8, 963-977.
94. Frayssinet, P.; Trouillet, J.L.; Rouquet, N.; Azimus, E.; Autefage, A. Osseointegration of macroporous calcium phosphate ceramics having a different chemical composition. Biomaterials 1993, 14, 423-429.
95. Holtorf, H.L.; Sheffield, T.L.; Ambrose, C.G.; Jansen, J.A.; Mikos, A.G. Flow perfusion culture of marrow stromal cells seeded on porous biphasic calcium phosphate ceramics. Ann. Biomed. Eng. 2005, 33, 1238-1248.
96. Arinzeh, T.L.; Tran, T.; McAlary, J.; Daculsi, G. A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. Biomaterials 2005, 26, 3631-3638.
97. Yuan, H.; van Blitterswijk, C.A.; de Groot, K.; de Bruijn, J.D. A comparison of bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) implanted in muscle and bone of dogs at different time periods. J. Biomed. Mater. Res. A 2006, 78, 139-147.
98. Yuan, H.; van Blitterswijk, C.A.; de Groot, K.; de Bruijn, J.D. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. Tissue Eng. 2006, 12, 1607-1615.
99. Ripamonti, U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 1996, 17, 31-35.
100. Kendoff, D.O.; Citak, M.; Egidy, C.C.; O'Loughlin, P.F.; Gehrke, T. Eleven-year results of the anatomic coated CFP stem in primary total hip arthroplasty. J. Arthroplast. 2013, 28, 1047-1051.
101. Karantana, A.; Hobson, S.; Dhar, S. The scandinavian total ankle replacement: Survivorship at 5 and 8 years comparable to other series. Clin. Orthop. Relat. Res. 2010, 468, 951-957.
102. Lu, X.; Leng, Y. Theoretical analysis of calcium phosphate precipitation in simulated body fluid. Biomaterials 2005, 26, 1097-1108.
103. Johnsson, M.S.; Nancollas, G.H. The role of brushite and octacalcium phosphate in apatite formation. Crit. Rev. Oral Biol. Med. 1992, 3, 61-82.
104. Walsh, D.; Tanaka, J. Preparation of a bone-like apatite foam cement. J. Mater. Sci. Mater. Med. 2001, 12, 339-343.
105. Redepenning, J.; Schlessinger, T.; Burnham, S.; Lippiello, L.; Miyano, J. Characterization of electrolytically prepared brushite and hydroxyapatite coatings on orthopedic alloys. J. Biomed. Mater. Res. 1996, 30, 287-294.
106. Ince, A.; Schutze, N.; Hendrich, C.; Thull, R.; Eulert, J.; Lohr, J.F. In vitro investigation of orthopedic titanium-coated and brushite-coated surfaces using human osteoblasts in the presence of gentamycin. J. Arthroplast. 2008, 23, 762-771.
107. Yuan, H.; Kurashina, K.; de Bruijn, J.D.; Li, Y.; de Groot, K.; Zhang, X. A preliminary study on osteoinduction of two kinds of calcium phosphate ceramics. Biomaterials 1999, 20, 1799-1806.
108. Yamasaki, H.; Sakai, H. Osteogenic response to porous hydroxyapatite ceramics under the skin of dogs. Biomaterials 1992, 13, 308-312.
109. Habibovic, P.; Sees, T.M.; van den Doel, M.A.; van Blitterswijk, C.A.; de Groot, K. Osteoinduction by biomaterials-physicochemical and structural influences. J. Biomed. Mater. Res. A 2006, 77, 747-762.
110. Kurashina, K.; Kurita, H.; Wu, Q.; Ohtsuka, A.; Kobayashi, H. Ectopic osteogenesis with biphasic ceramics of hydroxyapatite and tricalcium phosphate in rabbits. Biomaterials 2002, 23, 407-412.
111. Klar, R.M.; Duarte, R.; Dix-Peek, T.; Dickens, C.; Ferretti, C.; Ripamonti, U. Calcium ions and osteoclastogenesis initiate the induction of bone formation by coral-derived macroporous constructs. J. Cell Mol. Med. 2013, 17, 1444-1457.
112. Rupp, F.; Scheideler, L.; Olshanska, N.; de Wild, M.; Wieland, M.; Geis-Gerstorfer. J. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J. Biomed. Mater. Res. A 2006, 76, 323-334.
113. Buser, D.; Broggini, N.; Wieland, M.; Schenk, R.K.; Denzer, A.J.; Cochran, D.L.; Hoffmann, B.; Lussi, A.; Steinemann, S.G. Enhanced bone apposition to a chemically modified SLA titanium surface. J. Dent. Res. 2004, 83, 529-533.
114. Lai, H.C.; Zhuang, L.F.; Zhang, Z.Y.; Wieland. M.; Liu, X. Bone apposition around two different sandblasted, large-grit and acid-etched implant surfaces at sites with coronal circumferential defects: An experimental study in dogs. Clin. Oral Implant. Res. 2009, 20, 247-253.
115. Michael, K.E.; Vernekar, V.N.; Keselowsky, B.G.; Meredith, J.C.; Latour, R.A.; García, A.J. Adsorption-induced conformational changes in fibronectin due to interactions with well-defined surface chemistries. Langmuir 2003, 19, 8033-8040.
116. Chen, X.B.; Li, Y.C.; Du Plessis, J.; Hodgson, P.D.; Wen, C. Influence of calcium ion deposition on apatite-inducing ability of porous titanium for biomedical applications. Acta Biomater. 2009, 5, 1808-1820.
117. Park, J.W.; Kim, Y.J.; Jang, J.H.; Song, H. Osteoblast response to magnesium ion-incorporated nanoporous titanium oxide surfaces. Clin. Oral Implant. Res. 2010, 21, 1278-1287.
118. Park, J.W.; An, C.H.; Jeong, S.H.; Suh, J.Y. Osseointegration of commercial microstructured titanium implants incorporating magnesium: A histomorphometric study in rabbit cancellous bone. Clin. Oral Implant. Res. 2012, 23, 294-300.
119. Cho, L.R.; Kim, D.G.; Kim, J.H.; Byon, E.S.; Jeong, Y.S.; Park, C.J. Bone response of Mg ion-implanted clinical implants with the plasma source ion implantation method. Clin. Oral Implant. Res. 2010, 21, 848-856.
120. Zreiqat, H.; Valenzuela, S.M.; Nissan, B.B.; Roest, R.; Knabe, C.; Radlanski, R.J.; Renz, H.; Evans, P.J. The effect of surface chemistry modification of titanium alloy on signalling pathways in human osteoblasts. Biomaterials 2005, 26, 7579-7586.
121. Zreiqat, H.; Howlett, C.R.; Zannettino, A.; Evans, P.; Schulze-Tanzil, G.; Knabe, C.; Shakibaei, M. Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J. Biomed. Mater. Res. 2002, 62, 175-184.
122. Park, J.W.; Kim, Y.J.; Jang, J.H.; Kwon, T.G.; Bae, Y.C.; Suh, J.Y. Effects of phosphoric acid treatment of titanium surfaces on surface properties, osteoblast response and removal of torque forces. Acta Biomater. 2010, 6, 1661-1670.
123. Park, J.W.; Jang, J.H.; Lee, C.S.; Hanawa, T. Osteoconductivity of hydrophilic microstructured titanium implants with phosphate ion chemistry. Acta Biomater. 2009, 5, 2311-2321.
124. Park, J.W.; Kim, Y.J.; Jang, J.H. Enhanced osteoblast response to hydrophilic strontium and/or phosphate ions-incorporated titanium oxide surfaces. Clin. Oral Implant. Res. 2010, 21, 398-408.
125. 2 grit-blasted c.p. titanium endosseous implants. Biomaterials 2006, 27, 926-936.
126. Isa, Z.M.; Schneider, G.B.; Zaharias, R.; Seabold, D.; Stanford, C.M. Effects of fluoride-modified titanium surfaces on osteoblast proliferation and gene expression. Int. J. Oral Maxillofac. Implant. 2006, 21, 203-211.
127. 2 grit blasted titanium implants on adherent osteoblast gene expression in vitro and in vivo. Biomaterials 2007, 28, 5418-5425.
128. Nayab, S.N.; Jones, F.H.; Olsen, I. Effects of calcium ion implantation on human bone cell interaction with titanium. Biomaterials 2005, 26, 4717-4727.
129. Viguet-Carrin, S.; Garnero, P.; Delmas, P.D. The role of collagen in bone strength. Osteoporos. Int. 2006, 17, 319-336.
130. Geissler, U.; Hempel, U.; Wolf, C.; Scharnweber, D.; Worch, H.; Wenzel, K. Collagen type I-coating of Ti6Al4V promotes adhesion of osteoblasts. J. Biomed. Mater. Res. 2000, 51, 752-760.
131. Morra, M.; Cassinelli, C.; Cascardo, G.; Mazzucco, L.; Borzini, P.; Fini, M.; Giavaresi, G.; Giardino, R. Collagen I-coated titanium surfaces: Mesenchymal cell adhesion and in vivo evaluation in trabecular bone implants. J. Biomed. Mater. Res. A 2006, 78, 449-458.
132. Le Guillou-Buffello, D.; Bareille, R.; Gindre, M.; Sewing, A.; Laugier, P.; Amedee, J. Additive effect of RGD coating to functionalized titanium surfaces on human osteoprogenitor cell adhesion and spreading. Tissue Eng. A 2008, 14, 1445-1455.
133. Rammelt, S.; Schulze, E.; Bernhardt, R.; Hanisch, U.; Scharnweber, D.; Worch, H.; Zwipp, H.; Biewener, A. Coating of titanium implants with type-I collagen. J. Orthop. Res. 2004, 22, 1025-1034.
134. Morra, M.; Cassinelli, C.; Meda, L.; Fini, M.; Giavaresi, G.; Giardino, R. Surface analysis and effects on interfacial bone microhardness of collagen-coated titanium implants: A rabbit model. Int. J. Oral Maxillofac. Implant. 2005, 20, 23-30.
135. Mathews, M.B.; Lozaityte, I. Sodium chondroitin sulfate-protein complexes of cartilage. I. Molecular weight and shape. Arch. Biochem. Biophys. 1958, 74, 158-174.
136. Ruoslahti, E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 1996, 12, 697-715.
137. Schuler, M.; Owen, G.R.; Hamilton, D.W.; de Wild, M.; Textor, M.; Brunette, D.M.; Tosatti, S.G. Biomimetic modification of titanium dental implant model surfaces using the RGDSP-peptide sequence: A cell morphology study. Biomaterials 2006, 27, 4003-4015.
138. Rezania, A.; Healy, K.E. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J. Orthop. Res. 1999, 17, 615-623.
139. Grzesik, W.J.; Robey, P.G. Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J. Bone Miner. Res. 1994, 9, 487-496.
140. Bell, B.F.; Schuler, M.; Tosatti, S.; Textor, M.; Schwartz, Z.; Boyan, B.D. Osteoblast response to titanium surfaces functionalized with extracellular matrix peptide biomimetics. Clin. Oral Implant. Res. 2011, 22, 865-872.
141. Kroese-Deutman, H.C.; van den Dolder, J.; Spauwen, P.H.; Jansen, J.A. Influence of RGD-loaded titanium implants on bone formation in vivo. Tissue Eng. 2005, 11, 1867-1875.
142. Puleo, D. A; Bizios, R. RGDS tetrapeptide binds to osteoblasts and inhibits fibronectin-mediated adhesion. Bone 1991, 12, 271-276.
143. Bagno, A.; Piovan, A.; Dettin, M.; Chiarion, A.; Brun, P.; Gambaretto, R.; Fontana, G.; Bello, C.D.; Palu, G.; Castagliuolo, I. Human osteoblast-like cell adhesion on titanium substrates covalently functionalized with synthetic peptides. Bone 2007, 40, 693-699.
144. Bitschnau, A.; Alt, V.; Bohner, F.; Heerich, K.E.; Margesin, E.; Hartmann, S.; Sewing, A.; Meyer, C.; Wenisch, S.; Schnettler, R. Comparison of new bone formation, implant integration, and biocompatibility between RGD-hydroxyapatite and pure hydroxyapatite coating for cementless joint prostheses-an experimental study in rabbits. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 88, 66-74.
145. Bogdanowich-Knipp, S.J.; Chakrabarti, S.; Williams, T.D.; Dillman, R.K.; Siahaan, T.J. Solution stability of linear vs. cyclic RGD peptides. J. Pept. Res. 1999, 53, 530-541.
146. Aumailley, M.; Gurrath, M.; Muller, G.; Calvete, J.; Timpl, R.; Kessler, H. Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 1991, 291, 50-54.
147. Porte-Durrieu, M.C.; Guillemot, F.; Pallu, S.; Labrugere, C.; Brouillaud, B.; Bareille, R.; Amedee, J.; Barthe, N.; Dard, M.; Baquey, C. Cyclo-(DfKRG) peptide grafting onto Ti-6Al-4V: Physical characterization and interest towards human osteoprogenitor cells adhesion. Biomaterials 2004, 25, 4837-4846.
148. Verrier, S.; Pallu, S.; Bareille, R.; Jonczyk, A.; Meyer, J.; Dard, M.; Amedee, J. Function of linear and cyclic RGD-containing peptides in osteoprogenitor cells adhesion process. Biomaterials 2002, 23, 585-596.
149. Elmengaard, B.; Bechtold, J.E.; Soballe, K. In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants. Biomaterials 2005, 26, 3521-3526.
150. Sottile, J.; Hocking, D.C.; Langenbach, K.J. Fibronectin polymerization stimulates cell growth by RGD-dependent and-independent mechanisms. J. Cell Sci. 2000, 113, 4287-4299.
151. McCarthy, J.B.; Skubitz, A.P.; Qi, Z.; Yi, X.Y.; Mickelson, D.J.; Klein, D.J.; Furcht, L.T. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and-independent activities. J. Cell Biol. 1990, 110, 777-787.
152. Aota, S.; Nomizu, M.; Yamada, K.M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J. Biol. Chem. 1994, 269, 24756-24761.
153. Hojo, K.; Susuki, Y.; Maeda, M.; Okazaki, I.; Nomizu, M.; Kamada, H.; Yamamoto, Y.; Nakagawa, S.; Mayumi, T.; Kawasaki, K. Amino acids and peptides. Part 39: A bivalent poly(ethylene glycol) hybrid containing an active site (RGD) and its synergistic site (PHSRN) of fibronectin. Bioorg. Med. Chem. Lett. 2001, 11, 1429-1432.
154. Benoit, D.S.; Anseth, K.S. The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials 2005, 26, 5209-5220.
155. Petrie, T.A.; Capadona, J.R.; Reyes, C.D.; Garcia, A.J. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. Biomaterials 2006, 27, 5459-5470.
156. Petrie, T.A.; Raynor, J.E.; Reyes, C.D.; Burns, K.L.; Collard, D.M.; Garcia, A.J. The effect of integrin-specific bioactive coatings on tissue healing and implant osseointegration. Biomaterials 2008, 29, 2849-2857.
157. Schliephake, H.; Aref, A.; Scharnweber, D.; Bierbaum, S.; Roessler, S.; Sewing, A. Effect of immobilized bone morphogenic protein 2 coating of titanium implants on peri-implant bone formation. Clin. Oral Implant. Res. 2005, 16, 563-569.
158. Kang, H.K.; Kim, O.B.; Min, S.K.; Jung, S.Y.; Jang, D.H.; Kwon, T.K.; Min, B.M.; Yeo, I.S. The effect of the DLTIDDSYWYRI motif of the human laminin α2 chain on implant osseointegration. Biomaterials 2013, 34, 4027-4037.
159. Jung, S.Y.; Kim, J.M.; Min, S.K.; Kim, O.B.; Jang, D.H.; Kang, H.K.; Min, B.M. The potential of laminin-2-biomimetic short peptide to promote cell adhesion, spreading and migration by inducing membrane recruitment and phosphorylation of PKCΔ. Biomaterials 2012, 33, 3967-3979.
160. Knight, C.G.; Morton, L.F.; Peachey, A.R.; Tuckwell, D.S.; Farndale, R.W.; Barnes, M.J. The collagen-binding A-domains of integrins α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J. Biol. Chem. 2000, 275, 35-40.
161. Reyes, C.D.; Petrie, T.A.; Burns, K.L.; Schwartz, Z.; Garcia, A.J. Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 2007, 28, 3228-3235.
162. Park, J.W.; Lee, S.G.; Choi, B.J.; Suh, J.Y. Effects of a cell adhesion molecule coating on the blasted surface of titanium implants on bone healing in the rabbit femur. Int. J. Oral Maxillofac. Implant. 2007, 22, 533-541.
163. Oh, S.; Brammer, K.S.; Li, Y.S.; Teng, D.; Engler, A.J.; Chien, S.; Jin, S. Stem cell fate dictated solely by altered nanotube dimension. Proc. Natl. Acad. Sci. USA 2009, 106, 2130-2135.
164. 2 nanotube diameter directs cell fate. Nano Lett. 2007, 7, 1686-1691.
165. Zhao, L.; Mei, S.; Chu, P.K.; Zhang, Y.; Wu, Z. The influence of hierarchical hybrid micro/nano-textured titanium surface with titania nanotubes on osteoblast functions. Biomaterials 2010, 31, 5072-5082.
166. Davies, J.E.; Ajami, E.; Moineddin, R.; Mendes, V.C. The roles of different scale ranges of surface implant topography on the stability of the bone/implant interface. Biomaterials 2013, 34, 3535-3546.
167. Ichinohe, N.; Kuboki, Y.; Tabata, Y. Bone regeneration using titanium nonwoven fabrics combined with fgf-2 release from gelatin hydrogel microspheres in rabbit skull defects. Tissue Eng. A 2008, 14, 1663-1671.
168. Suzuki, T.; Hayakawa, T.; Kawamoto, T.; Gomi, K. Bone response of TGF-β2 immobilized titanium in a rat model. Dent. Mater. J. 2014, 33, 233-241.
169. Sumner, D.R.; Turner, T.M.; Urban, R.M.; Leven, R.M.; Hawkins, M.; Nichols, E.H.; McPherson, J.M.; Galante, J.O. Locally delivered rhTGF-beta2 enhances bone ingrowth and bone regeneration at local and remote sites of skeletal injury. J. Orthop. Res. 2001, 19, 85-94.
170. Vehof, J.W.; Mahmood, J.; Takita, H.; van't Hof, M.A.; Kuboki, Y.; Spauwen, P.H.; Jansen, J.A. Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate. Plast. Reconstr. Surg. 2001, 108, 434-443.
171. Kimura, Y.; Miyazaki, N.; Hayashi, N.; Otsuru, S.; Tamai, K.; Kaneda, Y.; Tabata, Y. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Tissue Eng. A 2010, 16, 1263-1270.
172. Nauth, A.; Ristevski, B.; Li, R.; Schemitsch, E.H. Growth factors and bone regeneration: How much bone can we expect? Injury 2011, 42, 574-579.
173. Yamamoto, M.; Takahashi, Y.; Tabata, Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 2003, 24, 4375-4383.
174. Carragee, E.J.; Hurwitz, E.L.; Weiner, B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J. 2011, 11, 471-491.
175. Hall, J.; Sorensen, R.G.; Wozney, J.M.; Wikesjo, U.M. Bone formation at rhBMP-2-coated titanium implants in the rat ectopic model. J. Clin. Periodontol. 2007, 34, 444-451.
176. Yuan, H.; Zou, P.; Yang, Z.; Zhang, X.; de Bruijn, J.D.; de Groot, K. Bone morphogenetic protein and ceramic-induced osteogenesis. J. Mater. Sci. Mater. Med. 1998, 9, 717-721.
177. Ono, I.; Gunji, H.; Kaneko, F.; Saito, T.; Kuboki, Y. Efficacy of hydroxyapatite ceramic as a carrier for recombinant human bone morphogenetic protein. J. Craniofac. Surg. 1995, 6, 238-244.
178. Tsuruga, E.; Takita, H.; Itoh, H.; Wakisaka, Y.; Kuboki, Y. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J. Biochem. 1997, 121, 317-324.
179. Gotz, H.E.; Muller, M.; Emmel, A.; Holzwarth, U.; Erben, R.G.; Stangl, R. Effect of surface finish on the osseointegration of laser-treated titanium alloy implants. Biomaterials 2004, 25, 4057-4064.
180. Kuboki, Y.; Jin, Q.; Takita, H. Geometry of carriers controlling phenotypic expression in BMP-induced osteogenesis and chondrogenesis. J. Bone Jt. Surg. Am. 2001, 83, S105-S115.
181. Liu, Y.; de Groot, K.; Hunziker, E.B. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 2005, 36, 745-757.
182. Kim, S.S.; Gwak, S.J.; Kim, B.S. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2. J. Biomed. Mater. Res. A 2008, 87, 245-253.
183. Bae, S.E.; de Groot, K.; Hunziker, E.B. Controlled release of bone morphogenetic protein (BMP)-2 from nanocomplex incorporated on hydroxyapatite-formed titanium surface. J. Control. Release 2012, 160, 676-684.
184. Schutzenberger, S.; Schultz, A.; Hausner, T.; Hopf, R.; Zanoni, G.; Morton, T.; Kropik, K.; van Griensven, M.; Redl, H. The optimal carrier for BMP-2: A comparison of collagen versus fibrin matrix. Arch. Orthop. Trauma Surg. 2012, 132, 1363-1370.
185. Geiger, M.; Li, R.H.; Friess, W. Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug Deliv. Rev. 2003, 55, 1613-1629.
186. Dawson, E.; La, W.G.; Cho, Y.M.; Shin, W.; Yeo, G.D.; Kim, B.S. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J. Bone Jt. Surg. Am. 2009, 91, 1604-1613.
187. Abarrategi, A.; Garcia-Cantalejo, J.; Moreno-Vicente, C.; Civantos, A.; Ramos, V.; Casado, J.V.; Perez-Rial, S.; Martnez-Corria, R.; Lopez-Lacomba, J.L. Gene expression profile on chitosan/rhBMP-2 films: A novel osteoinductive coating for implantable materials. Acta Biomater. 2009, 5, 2633-2646.
188. Abarrategi, A.; Goto, T.; Kodama, T.; Miyazaki, T.; Kobayashi, S.; Takahashi, T. Chitosan film as rhBMP2 carrier: Delivery properties for bone tissue application. Biomacromolecules 2008, 9, 711-718.
189. Yang, H.S.; Larkin, A.L.; Rajagopalan, P. Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration. Exp. Mol. Med. 2012, 44, 350-355.
190. Ishibe, T.; Gilde, F.; Becquart, P.; Sailhan, F.; Lapeyrere, A.; Logeart-Avramoglou, D. Bone formation on apatite-coated titanium with incorporated BMP-2/heparin in vivo. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2009, 108, 867-875.
191. Macdonald, M.L.; Samuel, R.E.; Shah, N.J.; Padera, R.F.; Beben, Y.M.; Hammond, P.T. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 2011, 32, 1446-1453.
192. Hu, Y.; Cai, K.; Luo, Z.; Zhang, Y.; Li, L.; Lai, M.; Hou, Y.; Huang, Y.; Li, J.; Ding, X.; et al. Regulation of the differentiation of mesenchymal stem cells in vitro and osteogenesis in vivo by microenvironmental modification of titanium alloy surfaces. Biomaterials 2012, 33, 3515-3528.
193. Shah, N.J.; Macdonald, M.L.; Beben, Y.M.; Padera, R.F.; Samuel, R.E.; Hammond, P.T. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Biomaterials 2011, 32, 6183-6193.
194. Jiang, Q.H.; Liu, L.; Shen, J.W.; Peel, S.; Yang, G.L.; Zhao, S.F.; He, F.M. Influence of multilayer rhBMP-2 DNA coating on the proliferation and differentiation of MC3T3-E1 cells seeded on roughed titanium surface. J. Biomed. Mater. Res. A 2012, 100, 2766-2774.
195. Hu, Y.; Liu, L.; Shen, J.W.; Peel, S.; Yang, G.L.; Zhao, S.F.; He, F.M. Surface mediated in situ differentiation of mesenchymal stem cells on gene-functionalized titanium films fabricated by layer-by-layer technique. Biomaterials 2009, 30, 3626-3635.
196. Qiao, C.; Cai, K.; Luo, Z.; Zhang, R.; Yang, L.; Deng, L.; Jandt, K.D. Using poly (lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo. Int. J. Nanomed. 2013, 8, 2985-2995.
197. 2 nanotubes as drug nanoreservoirs for the regulation of mobility and differentiation of mesenchymal stem cells. Acta Biomater. 2012, 8, 439-448.
198. 2 nanotubes with bone morphogenetic protein 2 and its synergistic effect on the differentiation of mesenchymal stem cells. Biomacromolecules 2011, 12, 1097-1105.
199. Ruppert, R.; Hoffmann, E.; Sebald, W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 1996, 237, 295-302.
200. Zhao, B.; Katagiri, T.; Toyoda, H.; Takada, T.; Yanai, T.; Fukuda, T.; Chung, U.I.; Koike, T.; Takaoka, K.; Kamijo, R. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J. Biol. Chem. 2006, 281, 23246-23253.
201. Yang, H.S.; Li, R.H.; Friess, W. Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-2. Tissue Eng. A 2010, 16, 1225-1233.
202. Detzel, C.J.; Larkin, A.L.; Rajagopalan, P. Polyelectrolyte multilayers in tissue engineering. Tissue Eng. B Rev. 2011, 17, 101-113.
203. Guillot, R.; Gilde, F.; Becquart, P.; Sailhan, F.; Lapeyrere, A.; Logeart-Avramoglou, D.; Picart, C. The stability of BMP loaded polyelectrolyte multilayer coatings on titanium. Biomaterials 2013, 34, 5737-5746.
204. Gerber, H.P.; Civantos, A.; Ramos, V.; Casado, J.V.S.; Lopez-Lacomba, J.L. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 1999, 5, 623-628.
205. Samee, M.; Cai, K.; Luo, Z.; Xu, D.; Xie, D.; Huang, Y. Bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J. Pharmacol. Sci. 2008, 108, 18-31.
206. Kang, Y.; Cai, K.; Zhao, L.; Chen, X.; Hou, Y.; Yang, Z. Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2. Biomaterials 2011, 32, 6119-6130.
207. Lugero, G.G.; de Falco, V.C.; Guzzo, M.L.; Konig, B., Jr.; Jorgetti, V. Histomorphometric evaluation of titanium implants in osteoporotic rabbits. Implant Dent. 2000, 9, 303-309.
208. Kurth, A.H.; Eberhardt, C.; Muller, S.; Steinacker, M.; Schwarz, M.; Bauss, F. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone 2005, 37, 204-210.
209. Saito, T.; Kin, Y.; Koshino, T. Osteogenic response of hydroxyapatite cement implanted into the femur of rats with experimentally induced osteoporosis. Biomaterials 2002, 23, 2711-2716.
210. Tateishi, H.; Okamoto, Y.; Kinoshita, K.; Hibi, H.; Ueda, M. Effects of implant surface on bone healing around titanium screw implants in ovariectomized rats. Int. J. Oral Maxillofac. Implant. 2013, 28, 252-259.
211. Duarte, P.M.; Neto, J.B.C.; Goncalves, P.F.; Sallum, E.A.; Nociti, J.F. Estrogen deficiency affects bone healing around titanium implants: A histometric study in rats. Implant Dent. 2003, 12, 340-346.
212. Gao, Y.; Zou, S.; Liu, X.; Bao, C.; Hu, J. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials 2009, 30, 1790-1796.
213. McKenzie, K.; Bobyn, J.D.; Roberts, J.; Karabasz, D.; Tanzer, M. Bisphosphonate remains highly localized after elution from porous implants. Clin. Orthop. Relat. Res. 2011, 469, 514-522.
214. Gao, Y.; Luo, E.; Hu, J.; Xue, J.; Zhu, S.; Li, J. Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats. Bone 2009, 44, 225-232.
215. Qi, M.; Hu, J.; Li, J.; Dong, W.; Feng, X.; Yu, J. Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits. Bone 2012, 50, 119-127.
216. Tengvall, P.; Skoglund, B.; Askendal, A.; Aspenberg, P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 2004, 25, 2133-2138.
217. Abtahi, J.; Tengvall, P.; Aspenberg, P. A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants. Bone 2012, 50, 1148-1151.
218. Luo, E.; Hu, J.; Bao, C.; Li, Y.; Tu, Q.; Murray, D.; Chen, J. Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits. Acta Biomater. 2012, 8, 734-743.
219. Alghamdi, H.S.; Bosco, R.; van de Beucken, J.J.; Walboomers, X.F.; Jansen, J.A. Osteogenicity of titanium implants coated with calcium phosphate or collagen type-I in osteoporotic rats. Biomaterials 2013, 34, 3747-3757.
220. Kajiwara, H.; Yamaza, T.; Yoshinari, M.; Goto, T.; Iyama, S.; Atsuta, I.; Kido, M.A.; Tanaka, T. The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats. Biomaterials 2005, 26, 581-587.
221. Yoshinari, M.; Oda, Y.; Inoue, T.; Matsuzaka, K.; Shimono, M. Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants. Biomaterials 2002, 23, 2879-2885.
222. Hurtel-Lemaire, A.S.; Mentaverri, R.; Caudrillier, A.; Cournarie, F.; Wattel, A.; Kamel, S.; Terwilliger, E.F.; Brown, E.M.; Brazier, M. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways. J. Biol. Chem. 2009, 284, 575-584.
223. D'Haese, P.C.; Schrooten, I.; Goodman, W.G.; Cabrera, W.E.; Lamberts, L.V.; Elseviers, M.M.; Couttenye, M.M.; de Broe, M.E. Increased bone strontium levels in hemodialysis patients with osteomalacia. Kidney Int. 2000, 57, 1107-1114.
224. Cohen-Solal, M. Strontium overload and toxicity: Impact on renal osteodystrophy. Nephrol. Dial. Transpl. 2002, 17, 30-34.
225. Andersen, O.Z.; Offermanns, V.; Sillassen, M.; Almtoft, K.P.; Andersen, I.H.; Sorensen, S.; Jeppesen, C.S.; Kraft, D.C.; Bottiger, J.; Rasse, M.; et al. Accelerated bone ingrowth by local delivery of strontium from surface functionalized titanium implants. Biomaterials 2013, 34, 5883-5890.
226. Park, J.W.; Kim, H.K.; Kim, Y.J.; Jang, J.H.; Song, H.; Hanawa, T. Osteoblast response and osseointegration of a Ti-6Al-4V alloy implant incorporating strontium. Acta Biomater. 2010, 6, 2843-2851.
227. Zhao, L.; Wang, H.; Huo, K.; Zhang, X.; Wang, W.; Zhang, Y.; Wu, Z.; Chu, P.K. The osteogenic activity of strontium loaded titania nanotube arrays on titanium substrates. Biomaterials 2013, 34, 19-29.
228. Delmi, M.; Vaudaux, P.; Lew, D.P.; Vasey, H. Role of fibronectin in staphylococcal adhesion to metallic surfaces used as models of orthopaedic devices. J. Orthop. Res. 1994, 12, 432-438.
229. Hickok, N.J.; Shapiro, I.M. Immobilized antibiotics to prevent orthopaedic implant infections. Adv. Drug Deliv. Rev. 2012, 64, 1165-1176.
230. Simchi, A.; Tamjid, E.; Pishbin, F.; Boccaccini, A.R. Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomedicine 2011, 7, 22-39.
231. Davies, D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2003, 2, 114-122.
232. Gristina, A.G. Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 1987, 237, 1588-1595.
233. Yoshinari, M.; Oda, Y.; Kato, T.; Okuda, K.; Hirayama, A. Influence of surface modifications to titanium on oral bacterial adhesion in vitro. J. Biomed. Mater. Res. 2000, 52, 388-394.
234. Harris, L.G.; Richards, R.G. Staphylococcus aureus adhesion to different treated titanium surfaces. J. Mater. Sci. Mater. Med. 2004, 15, 311-314.
235. Duarte, P.M.; Reis, A.F.; de Freitas, P.M.; Ota-Tsuzuki, C. Bacterial adhesion on smooth and rough titanium surfaces after treatment with different instruments. J. Periodontol. 2009, 80, 1824-1832.
236. Riedewald, F. Bacterial adhesion to surfaces: The influence of surface roughness. PDA J. Pharm. Sci. Technol. 2006, 60, 164-171.
237. Ivanova, E.P.; Truong, V.K.; Wang, J.Y.; Berndt, C.C.; Jones, R.T.; Yusuf, Il; Peake, I.; Schmidt, H.W.; Fluke, C.; Barnes, D.; et al. Impact of nanoscale roughness of titanium thin film surfaces on bacterial retention. Langmuir 2010, 26, 1973-1982.
238. Truong, V.K.; Lapovok, R.; Estrin, Y.S.; Rundell, S.; Wang, J.Y.; Fluke, C.J.; Crawford, R.J.; Ivanova, E.P. The influence of nano-scale surface roughness on bacterial adhesion to ultrafine-grained titanium. Biomaterials 2010, 31, 3674-3683.
239. Truong, V.K.; Rundell, S.; Lapovok, R.; Estrin, Y.; Wang, J.Y.; Berndt, C.C.; Barnes, D.G.; Fluke, C.J.; Crawford, R.J.; Ivanova, E.P. Effect of ultrafine-grained titanium surfaces on adhesion of bacteria. Appl. Microbiol. Biotechnol. 2009, 83, 925-937.
240. Mitik-Dineva, N.; Wang, J.; Truong, V.K.; Stoddart, P.; Malherbe, F.; Crawford, R.J.; Ivanova, E.P. Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus attachment patterns on glass surfaces with nanoscale roughness. Curr. Microbiol. 2009, 58, 268-273.
241. Teughels, W.; van Assche, N.; Sliepen, I.; Quirynen, M. Effect of material characteristics and/or surface topography on biofilm development. Clin. Oral Implant. Res. 2006, 17, 68-81.
242. Chung, K.K.; Schumacher, J.F.; Sampson, E.M.; Burne, R.A.; Antonelli, P.J.; Brennan, A.B. Impact of engineered surface microtopography on biofilm formation of Staphylococcus aureus. Biointerphases 2007, 2, 89-94.
243. Feng, Q.L.; Wu, J.; Chen, G.Q.; Cui, F.Z.; Kim, T.N.; Kim, J.O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Mater. Res. 2000, 52, 662-668.
244. Chen, W.; Oh, S.; Ong, A.P.; Oh, N.; Liu, Y.; Courtney, H.S.; Appleford, M.; Ong, J.L. Antibacterial and osteogenic properties of silver-containing hydroxyapatite coatings produced using a sol gel process. J. Biomed. Mater. Res. A 2007, 82, 899-906.
245. Gosheger, G.; Hardes, J.; Ahrens, H.; Streitburger, A.; Buerger, H.; Erren, M.; Gunsel, A.; Kemper, F.H.; Winkelmann, W.; Von Eiff, C. Silver-coated megaendoprostheses in a rabbit model-an analysis of the infection rate and toxicological side effects. Biomaterials 2004, 25, 5547-5556.
246. Collinge, C.A.; Goll, G.; Seligson, D.; Easley, K.J. Pin tract infections: Silver vs. uncoated pins. Orthopedics 1994, 17, 445-448.
247. Masse, A.; Bruno, A.; Bosetti, M.; Biasibetti, A.; Cannas, M.; Gallinaro, P. Prevention of pin track infection in external fixation with silver coated pins: Clinical and microbiological results. J. Biomed. Mater. Res. 2000, 53, 600-604.
248. Coester, L.M.; Nepola, J.V.; Allen, J.; Marsh, J.L. The effects of silver coated external fixation pins. Iowa Orthop. J. 2006, 26, 48-53.
249. Song, W.H.; Ryu, H.S.; Hong, S.H. Antibacterial properties of Ag (or Pt)-containing calcium phosphate coatings formed by micro-arc oxidation. J. Biomed. Mater. Res. A 2009, 88, 246-254.
250. Zhao, L.; Wang, H.; Huo, K.; Cui, L.; Zhang, W.; Ni, H.; Zhang, Y.; Wu, Z.; Chu, P.K. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 2011, 32, 5706-5716.
251. Li, P.W.; Kuo, T.H.; Chang, J.H.; Yeh, J.M.; Chan, W.H. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol. Lett. 2010, 197, 82-87.
252. Rameshbabu, N.; Kumar, T.S.S.; Prabhakar, T.G.; Sastry, V.S.; Murty, K.V.; Rao, K. Antibacterial nanosized silver substituted hydroxyapatite: Synthesis and characterization. J. Biomed. Mater. Res. A 2007, 80, 581-591.
253. Feng, Q.L.; Kim, T.N.; Wu, J.; Park, E.S.; Kim, J.O.; Lim, D.Y.; Cui, F.Z. Antibacterial effects of Ag-HAp thin films on alumina substrates. Thin Solid Films 1998, 335, 214-219.
254. Chen, W.; Liu, Y.; Courtney, H.S.; Bettenga, M.; Agrawal, C.M.; Bumgardner, J.D.; Ong, J.L. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials 2006, 27, 5512-5517.
255. Shirkhanzadeh, M.; Azadegan, M.; Liu, G.Q. Bioactive delivery systems for the slow release of antibiotics: Incorporation of Ag+ ions into micro-porous hydroxyapatite coatings. Mater. Lett. 1995, 24, 7-12.
256. Kumar, R.; Munstedt, H. Silver ion release from antimicrobial polyamide/silver composites. Biomaterials 2005, 26, 2081-2088.
257. Fu, J.; Ji, J.; Fan, D.; Shen, J. Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chitosan-silver ions complex. J. Biomed. Mater. Res. A 2006, 79, 665-674.
258. Kelly, P.J.; Li, H.; Whitehead, K.A.; Verran, J.; Arnell, R.D.; Iordanova, I. A study of the antimicrobial and tribological properties of TiN/Ag nanocomposite coatings. Surf. Coat. Technol. 2009, 204, 1137-1140.
259. Sánchez-López, J.C.; Abad, M.D.; Carvalho, I.; Galindo, R.E.; Benito, N.; Ribeiro, S.; Henriques, M.; Cavaleiro, A.; Carvalho, S. Influence of silver content on the tribomechanical behavior on Ag-TiCN bioactive coatings. Surf. Coat. Technol. 2012, 206, 2192-2198.
260. Kelly, P.J.; Li, H.; Benson, P.S.; Whitehead, K.A.; Verran, J.; Arnell, R.D.; Iordanova, I. Comparison of the tribological and antimicrobial properties of CrN/Ag, ZrN/Ag, TiN/Ag, and TiN/Cu nanocomposite coatings. Surf. Coat. Technol. 2010, 205, 1606-1610.
261. Pappas, M.J.; Makris, G.; Buechel, F.F. Titanium nitride ceramic film against polyethylene. A 48 million cycle wear test. Clin. Orthop. Relat. Res. 1995, 317, 64-70.
262. Ward, L.P.; Subramanian, C.; Strafford, K.N.; Wilks, T.P. Sliding wear studies of selected nitride coatings and their potential for long-term use in orthopaedic applications. Proc. Inst. Mech. Eng. H 1998, 212, 303-315.
263. Gispert, M.P.; Serro, A.P.; Colaço, R.; Pires, E.; Saramago, B. Wear of ceramic coated metal-on-metal bearings used for hip replacement. Wear 2007, 263, 1060-1065.
264. Raimondi, M.T.; Pietrabissa, R. The in vivo wear performance of prosthetic femoral heads with titanium nitride coating. Biomaterials 2000, 21, 907-913.
265. Zhao, J.; Feng, H.J.; Tang, H.Q.; Zheng, J.H. Bactericidal and corrosive properties of silver implanted TiN thin films coated on AISI317 stainless steel. Surf. Coat. Technol. 2007, 201, 5676-5679.
266. McMullin, B.B.; Chittock, D.R.; Roscoe, D.L.; Garcha, H.; Wang, L.; Miller, C.C. The antimicrobial effect of nitric oxide on the bacteria that cause nosocomial pneumonia in mechanically ventilated patients in the intensive care unit. Respir. Care 2005, 50, 1451-1456.
267. Charville, G.W.; Hetrick, E.M.; Geer, C.B.; Schoenfisch, M.H. Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release. Biomaterials 2008, 29, 4039-4044.
268. Hetrick, E.M.; Schoenfisch, M.H. Reducing implant-related infections: Active release strategies. Chem. Soc. Rev. 2006, 35, 780-789.
269. Frost, M.C.; Reynolds, M.M.; Meyerhoff, M.E. Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices. Biomaterials 2005, 26, 1685-1693.
270. Zhou, Z.; Meyerhoff, M.E. Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin. Biomaterials 2005, 26, 6506-6517.
271. Rabea, E.I.; Badawy, M.E.; Stevens, C.V.; Smagghe, G.; Steurbaut, W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 2003, 4, 1457-1465.
272. Fu, J.; Ji, J.; Yuan, W.; Shen, J. Construction of anti-adhesive and antibacterial multilayer films via layer-by-layer assembly of heparin and chitosan. Biomaterials 2005, 26, 6684-6692.
273. Xiao, B.; Wan, Y.; Zhao, M.; Liu, Y.; Zhang, S. Preparation and characterization of antimicrobial chitosan-N-arginine with different degrees of substitution. Carbohydr. Polym. 2011, 83, 144-150.
274. Feng, Y.; Xia, W. Preparation, characterization and antibacterial activity of water-soluble O-fumaryl-chitosan. Carbohydr. Polym. 2011, 83, 1169-1173.
275. Doulabi, A.H.; Mirzadeh, H.; Imani, M.; Samadi, N. Chitosan/polyethylene glycol fumarate blend film: Physical and antibacterial properties. Carbohydr. Polym. 2013, 92, 48-56.
276. Zhong, Z.; Xing, R.; Liu, S.; Wang, L.; Cai, S.; Li, P. Synthesis of acyl thiourea derivatives of chitosan and their antimicrobial activities in vitro. Carbohydr. Res. 2008, 343, 566-570.
277. Tan, H.; Ma, R.; Lin, C.; Liu, Z.; Tang, T. Quaternized chitosan as an antimicrobial agent: Antimicrobial activity, mechanism of action and biomedical applications in orthopedics. Int. J. Mol. Sci. 2013, 14, 1854-1869.
278. He, G.; Chen, X.; Yin, Y.; Zheng, H.; Xiong, X.; Du, Y. Synthesis, characterization and antibacterial activity of salicyloyl chitosan. Carbohydr. Polym. 2011, 83, 1274-1278.
279. 2 reaction: Toward an understanding of its killing mechanism. Appl. Environ. Microbiol. 1999, 65, 4094-4098.
280. Cheng, C.L.; Sun, D.S.; Chu, W.C.; Tseng, Y.H.; Ho, H.C.; Wang, J.B.; Chung, P.H.; Chen, J.H.; Tsai, P.J.; Lin, N.T.; et al. The effects of the bacterial interaction with visible-light responsive titania photocatalyst on the bactericidal performance. J. Biomed. Sci. 2009, 16, doi: 10.1186/1423-0127-16-7.
281. Huang, Z.; Maness, P.-C.; Blake, D.M.; Wolfrum, E.J.; Smolinski, S.L.; Jacoby, W.A. Bactericidal mode of titanium dioxide photocatalysis. J. Photochem. Photobiol. A Chem. 2000, 130, 163-170.
282. 2 thin film photocatalysts. Environ. Sci. Technol. 1998, 32, 726-728.
283. Seery, M.K.; George, R.; Floris, P.; Pillai, S.C. Silver doped titanium dioxide nanomaterials for enhanced visible light photocatalysis. J. Photochem. Photobiol. A Chem. 2007, 189, 258-263.
284. 2 impregnated with Ag nanoparticles applied in photoelectrocatalytic disinfection. J. Photochem. Photobiol. A Chem. 2014, 278, 1-8.
285. Bunetel, L.; Segui, A.; Cormier, M.; Percheron, E.; Langlais, F. Release of gentamicin from acrylic bone cement. Clin. Pharmacokinet. 1989, 17, 291-297.
286. Klekamp, J.; Dawson, J.M.; Haas, D.W.; DeBoer, D.; Christie, M. The use of vancomycin and tobramycin in acrylic bone cement: Biomechanical effects and elution kinetics for use in joint arthroplasty. J. Arthroplast. 1999, 14, 339-346.
287. Persson, C.; Baleani, M.; Guandalini, L.; Tigani, D.; Viceconti, M. Mechanical effects of the use of vancomycin and meropenem in acrylic bone cement. Acta Orthop. 2006, 77, 617-621.
288. Teupe, C.; Meffert, R.; Winckler, S.; Ritzerfeld, W.; Tormala, P.; Brug, E. Ciprofloxacin-impregnated poly-L-lactic acid drug carrier. New aspects of a resorbable drug delivery system in local antimicrobial treatment of bone infections. Arch. Orthop. Trauma Surg. 1992, 112, 33-35.
289. Koort, J.K.; Makinen, T.J.; Suokas, E.; Veiranto, M.; Jalava, J.; Tormala, P.; Aro, H.T. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant. Acta Orthop. 2008, 79, 295-301.
290. Price, J.S.; Tencer, A.F.; Arm, D.M.; Bohach, G.A. Controlled release of antibiotics from coated orthopedic implants. J. Biomed. Mater. Res. 1996, 30, 281-286.
291. Kalicke, T.; Schierholz, J.; Schlegel, U.; Frangen, T.M.; Koller, M.; Printzen, G.; Seybold, D.; Klockner, S.; Muhr, G.; Arens, S. Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: An in vitro and in vivo study. J. Orthop. Res. 2006, 24, 1622-1640.
292. Lucke, M.; Wildemann, B.; Sadoni, S.; Surke, C.; Schiller, R.; Stemberger, A.; Raschke, M.; Haas, N.P.; Schmidmaier, G. Systemic vs. local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone 2005, 36, 770-778.
293. Strobel, C.; Schmidmaier, G.; Wildemann, B. Changing the release kinetics of gentamicin from poly(D, L-lactide) implant coatings using only one polymer. Int. J. Artif. Organs 2011, 34, 304-316.
294. Alt, V.; Bitschnau, A.; Osterling, J.; Sewing, A.; Meyer, C.; Kraus, R.; Meissner, S.A.; Wenisch, S.; Domann, E.; Schnettler, R. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 2006, 27, 4627-4634.
295. Shirtliff, M.E.; Calhoun, J.H.; Mader, J.T. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite. Clin. Orthop. Relat. Res. 2002, 401, 239-247.
296. Popat, K.C.; Eltgroth, M.; Latempa, T.J.; Grimes, C.A.; Desai, T.A. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials 2007, 28, 4880-4888.
297. Lin, W.T.; Tan, H.L.; Duan, Z.L.; Yue, B.; Ma, R.; He, G.; Tang, T.T. Inhibited bacterial biofilm formation and improved osteogenic activity on gentamicin-loaded titania nanotubes with various diameters. Int. J. Nanomed. 2014, 9, 1215-1230.
298. Neut, D.; van de Belt, H.; Stokroos, I.; van Horn, J.R.; van der Mei, H.C.; Busscher, H.J. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J. Antimicrob. Chemother. 2001, 47, 885-891.
299. Antoci, V., Jr.; King, S.B.; Jose, B.; Parvizi, J.; Zeiger, A.R.; Wickstrom, E.; Freeman, T.A.; Composto, R.J.; Ducheyne, P.; Shapiro, I.M.; et al. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J. Orthop. Res. 2007, 25, 858-866.
300. Antoci, V., Jr.; Adams, C.S.; Parvizi, J.; Davidson, H.M.; Composto, R.J.; Freeman, T.A.; Wickstrom, E.; Ducheyne, P.; Jungkind, D.; Shapiro, I.M.; et al. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 2008, 29, 4684-4690.
301. Antoci, V., Jr.; Adams, C.S.; Parvizi, J.; Ducheyne, P.; Shapiro, I.M.; Hickok, N.J. Covalently attached vancomycin provides a nanoscale antibacterial surface. Clin. Orthop. Relat. Res. 2007, 461, 81-87.
302. Hwang, P.M.; Vogel, H.J. Structure-function relationships of antimicrobial peptides. Biochem. Cell Biol. 1998, 76, 235-246.
303. Gabriel, M.; Nazmi, K.; Veerman, E.C.; Amerongen, A.V.N.; Zentner, A. Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjugate Chem. 2006, 17, 548-550.
304. Hequet, A.; Humblot, V.; Berjeaud, J.M.; Pradier, C.M. Optimized grafting of antimicrobial peptides on stainless steel surface and biofilm resistance tests. Colloids Surf. B Biointerfaces 2011, 84, 301-309.